Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 8Terminated 4Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 9Uterine Cervical Neoplasms 5Vaginal Neoplasms 2Radiation Injuries 2Endometrial Neoplasms 2Breast Neoplasms 2Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroectodermal Tumors, Primitive, Peripheral 1Metastatic Malignant Female Reproductive System Neoplasm 1Gynecologic Cancer 1Desmoplastic Small Round Cell Tumor 1Carcinosarcoma 1Carcinoma, Ductal 1

Interventions

Paclitaxel 62Letrozole 55Fulvestrant 55Trastuzumab 50palbociclib 41pembrolizumab 37Cyclophosphamide 37Carboplatin 37Anastrozole 37pertuzumab 35exemestane 25Tamoxifen 24Capecitabine 24ribociclib 23abemaciclib 23Radiotherapy 21Docetaxel 21olaparib 20Doxorubicin 20Magnetic Resonance Spectroscopy 19trastuzumab deruxtecan 17Surveys and Questionnaires 17durvalumab 16Epirubicin 16Specimen Handling 14Exercise 14130-nm albumin-bound paclitaxel 14Taxes 13Alpelisib 13Goserelin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms × Brachytherapy × Clear all
NCT00185744 2026-03-20

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Stanford University

Phase NA Active not recruiting
121 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal

NCT05663294 2025-02-03

PRISCILLA

Istituto Clinico Humanitas

Phase NA Active not recruiting
150 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡